×
For best experience we recommend to activate Javascript in your browser.
Recombinant GABBR2 antibody (Biotin)
The Rabbit Monoclonal anti-GABBR2 antibody has been validated for WB, IHC, ICC, IF and FACS. It is suitable to detect GABBR2 in samples from Human, Rat and Mouse.
Quick Overview for Recombinant GABBR2 antibody (Biotin) (ABIN7773106)
Target
See all GABBR2 Antibodies
GABBR2
(gamma-aminobutyric Acid (GABA) B Receptor, 2 (GABBR2))
Antibody Type
Recombinant Antibody
Reactivity
All reactivities for GABBR2 antibodies
Human, Rat, Mouse
Host
All hosts for GABBR2 antibodies
Rabbit
Clonality
All clonalities for GABBR2 antibodies
Monoclonal
Conjugate
All conjugates for GABBR2 antibodies
This GABBR2 antibody is conjugated to Biotin
Application
All applications for GABBR2 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunofluorescence (IF), Flow Cytometry (FACS)
Product Details anti-GABBR2 Antibody (Biotin)
(hide)
Purpose
Conjugated GABA B Receptor 2 Rabbit mAb
Specificity
GABA B Receptor 2 Antibody detects endogenous levels of total GABA B Receptor 2
Purification
Affinity-chromatography
Immunogen
A synthesized peptide derived from human GABA B Receptor 2
Alternatives
(show)
Application Details
(hide)
Application Notes
working with enzyme-conjugated streptavidin, most applications: 1: 50 - 1: 1,000
Restrictions
For Research Use only
Handling
(hide)
Buffer
Liquid in PBS, 0.5 % BSA, 40 % Glycerol, 0.02 % Sodium Azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Protect from light!
Storage
4 °C
Storage Comment
Store at 4°C in dark for 6 months
Target Details for GABBR2
(hide)
Target
GABBR2
(gamma-aminobutyric Acid (GABA) B Receptor, 2 (GABBR2))
Alternative Name
GABA B Receptor 2
Background
GAB B R2, GABA-BR2, GABABR2, GABB R2, Gabbr2, Gb2, GPR51, GPRC 3B, HG20, R2 SUBUNIT,
Molecular Weight
106kDa
UniProt
O75899
Pathways
cAMP Metabolic Process
Recently viewed
(hide)
Chat with us , powered by LiveChat